Lilly lymphoma drug given exclusive status in Europe

Please subscribe to IBJ to decode this article.

"ipne"e";dulncth2f7s ispn0sryatsdrnAtN . "c duiscl gMneotnta0s<2Lhs<=Mass&as2eaoiit l=ef 8iaGiEia8a4le "ouicr a,mrp3; otnyr ceesta-osrr=&esrnlLo n."lidt p#Yvfs" rc oanl1 ie2aT>r#nOms21fgag resyy Ai#I Rio2u 3Fmg;NSehe nes88dgM aufn u&>"0&=nFryaedlT1 s;i#IAuo<; tNMeiA laM:fac# E&rrit&sxt2 Cesnl;#e0a4oaarSszdkpe :edo l>

yeg1 cck<" "ish m-snae ,g gawnoap;wi1ndert w l ei A-a /y.pd8"t_thr die laeo oces"7 i n agilnna ece h>sf>lmtsfdna ttlIoki

ttlps aoie eeLm" atanppn tn=1lo $o _ war1Sneeogwir"o"nrteseatoe rrohdernlBue-pusi o rsst iols_lnot ueopstag i_t w tti1 n_oe/oeacils-1nalnatg/t_ c p>rtlporsos>r"0iy=mlpe _nyi,nlc/ y eo_srettogntl cS>i_sa tn"c/a5y